Holen Sie sich die Stockscreener-App
4.055
0.62%
0.025
Aquestive Therapeutics Inc Aktie (AQST) Neueste Nachrichten
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha
Class Action Lawsuit Filed Against Aquestive Therapeutics - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - PR Newswire
Aquestive Therapeutics Investors Eligible for Securities Fraud Lawsuit - National Today
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Financial Times
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - Bluefield Daily Telegraph
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aquestive therapeutics chief legal officer Braender sells $167k in stock - Investing.com Canada
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - The Killeen Daily Herald
Aquestive Therapeutics SVP Cioffi sells $105k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock By Investing.com - Investing.com Canada
Aquestive Therapeutics SVP Cioffi sells $105k in shares - Investing.com
Aquestive Therapeutics CEO Barber sells $753,965 in stock - Investing.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) COO Sells 45,791 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Peter Boyd Sells 29,814 Shares - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) SVP Melina Cioffi Sells 25,311 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CFO Sells 58,254 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Lori Braender Sells 40,102 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CEO Sells 180,677 Shares of Stock - MarketBeat
AQST Investors Encouraged to Seek Lead Plaintiff Role in Aquestive Therapeutics Securities Class Action Case with Johnson Fistel - lincolnjournal.com
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
HC Wainwright Issues Optimistic Forecast for AQST Earnings - MarketBeat
Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval - Seeking Alpha
Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data - MarketBeat
AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST - GlobeNewswire Inc.
Rosen Law Firm Urges Aquestive Therapeutics, Inc. (NASDAQ: AQST) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
What’s the RSI of Aquestive Therapeutics Inc. stockWeekly Trading Summary & Intraday High Probability Setup Alerts - mfd.ru
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky - Business Wire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) S - GuruFocus
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-03-10 | AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
What is HC Wainwright's Estimate for AQST FY2027 Earnings? - MarketBeat
Aquestive Therapeutics Targets Q3 Anaphylm FDA Resubmission After CRL, Details Launch Plans at Leerink Conf - MarketBeat
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Aquestive CMO gets 75,000 RSUs plus 50,000 stock options to join company - Stock Titan
Contact Levi & Korsinsky by May 4, 2026 Deadline to Join Class Action Against Aquestive Therapeutics, Inc.(AQST) - GlobeNewswire
AQST Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
2026-03-09 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch - TipRanks
Market Review: Will Aquestive Therapeutics Inc benefit from government policyGlobal Markets & Stepwise Trade Signal Implementation - baoquankhu1.vn
AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-08) - Seeking Alpha
2026-03-08 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Will Aquestive Therapeutics Inc. stock continue upward momentumPortfolio Profit Report & Expert-Curated Trade Recommendations - Naître et grandir
US Market Wrap: How Aquestive Therapeutics Inc. stock reacts to global recession fears2025 Market WrapUp & AI Based Buy/Sell Signal Reports - Naître et grandir
AI Execution Risks Threaten Aquestive Therapeutics’ Competitiveness and Profitability - The Globe and Mail
Blue Owl Capital Holdings LP Has $6.99 Million Position in Aquestive Therapeutics, Inc. $AQST - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Upgraded at Wall Street Zen - MarketBeat
Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN
AQST Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Aquestive Therapeutics, Inc. - The Malaysian Reserve
AQUESTIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQUESTIVE THERAPEUTICS, INC. (AQST) INVESTOR ALERT Investors With Large Losses in Aquestive ... - Bluefield Daily Telegraph
AQUESTIVE THERAPEUTICS, INC. (AQST) INVESTOR ALERT - GlobeNewswire
Class Action Lawsuit Filed on Behalf of Aquestive Therapeutics, Inc. (AQST) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - marketscreener.com
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Aquestive Therapeutics - galvnews.com
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2025 Earnings Call Transcript - Insider Monkey
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics - Sahm
Robbins LLP Informs Investors of Aquestive Therapeutics Class Action Lawsuit - National Today
0.66%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):